SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001079973-24-000580
Filing Date
2024-04-22
Accepted
2024-04-22 16:30:41
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 toi_10ka.htm   iXBRL 10-K/A 593164
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 3318
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 3334
  Complete submission text file 0001079973-24-000580.txt   929169

Data Files

Seq Description Document Type Size
4 XBRL PRESENTATION FILE toi-20231231_pre.xml EX-101.PRE 27270
5 XBRL SCHEMA FILE toi-20231231.xsd EX-101.SCH 3709
6 XBRL DEFINITION FILE toi-20231231_def.xml EX-101.DEF 28661
7 XBRL LABEL FILE toi-20231231_lab.xml EX-101.LAB 39557
19 EXTRACTED XBRL INSTANCE DOCUMENT toi_10ka_htm.xml XML 8957
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 843562323 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39248 | Film No.: 24861559
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)